The mesh implant uses a process called mechanotransduction in which soft tissue remodels in responses to the stimulus of increased mechanical load. The mesh implant encourages regenerated tissue to grow that replaces the degraded mesh, which disappears after three years.
Related Articles on Medical Devices:
Study: Automated Suturing Lowers Operating Time, Cost
How Technology Has Changed the Medical Industry
Medical Device Makers’ Confidence Levels at Lowest Since 2009
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.